Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- PMID: 25865049
- DOI: 10.1053/j.gastro.2015.04.005
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
Abstract
Background & aims: It is not clear how weight loss affects histologic features of liver in patients with nonalcoholic steatohepatitis (NASH). We examined the association between the magnitude of weight loss through lifestyle modifications and changes in histologic features of NASH.
Methods: We conducted a prospective study of 293 patients with histologically proven NASH who were encouraged to adopt recommended lifestyle changes to reduce their weight over 52 weeks, from June 2009 through May 2013, at a tertiary medical center in Havana, Cuba. Liver biopsies were collected when the study began and at week 52 of the diet and were analyzed histologically.
Results: Paired liver biopsies were available from 261 patients. Among 293 patients who underwent lifestyle changes for 52 weeks, 72 (25%) achieved resolution of steatohepatitis, 138 (47%) had reductions in nonalcoholic fatty liver disease activity score (NAS), and 56 (19%) had regression of fibrosis. At week fifty-two, 88 subjects (30%) had lost ≥5% of their weight. Degree of weight loss was independently associated with improvements in all NASH-related histologic parameters (odds ratios = 1.1-2.0; P < .01). A higher proportion of subjects with ≥5% weight loss had NASH resolution (51 of 88 [58%]) and a 2-point reduction in NAS (72 of 88 [82%]) than subjects who lost <5% of their weight (P < .001). All patients who lost ≥10% of their weight had reductions NAS, 90% had resolution of NASH, and 45% had regression of fibrosis. All patients who lost 7%-10% of their weight and had few risk factors also had reduced NAS. In patients with baseline characteristics that included female sex, body mass index ≥35, fasting glucose >5.5 mmol/L, and many ballooned cells, NAS scores decreased significantly with weight reductions ≥10%.
Conclusions: A greater extent of weight loss, induced by lifestyle changes, is associated with the level of improvement in histologic features of NASH. The highest rates of NAS reduction, NASH resolution, and fibrosis regression occurred in patients with weight losses ≥10%.
Keywords: BMI; Lifestyle Intervention; NAFLD Activity Score; Resolution of Steatohepatitis.
Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.
Comment in
-
Reply: To PMID 25865049.Gastroenterology. 2015 Dec;149(7):1988-9. doi: 10.1053/j.gastro.2015.10.040. Epub 2015 Oct 26. Gastroenterology. 2015. PMID: 26515488 No abstract available.
-
Low Carbohydrate Rather Than Low Fat Is More Important in Dietary Management of Nonalcoholic Steatohepatitis.Gastroenterology. 2015 Dec;149(7):1987-8. doi: 10.1053/j.gastro.2015.09.044. Epub 2015 Oct 26. Gastroenterology. 2015. PMID: 26515490 No abstract available.
-
[Weight loss can cure fatty liver].MMW Fortschr Med. 2015 Sep 24;157(16):38. MMW Fortschr Med. 2015. PMID: 26783621 German. No abstract available.
Similar articles
-
Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.Gastroenterology. 2015 Aug;149(2):379-88; quiz e15-6. doi: 10.1053/j.gastro.2015.04.014. Epub 2015 Apr 25. Gastroenterology. 2015. PMID: 25917783
-
Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression.Scand J Gastroenterol. 2012 Jan;47(1):108-15. doi: 10.3109/00365521.2011.634024. Epub 2011 Nov 30. Scand J Gastroenterol. 2012. PMID: 22126450
-
Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.Gut. 2010 Jul;59(7):969-74. doi: 10.1136/gut.2009.205088. Gut. 2010. PMID: 20581244
-
Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.Minerva Gastroenterol Dietol. 2010 Jun;56(2):159-67. Minerva Gastroenterol Dietol. 2010. PMID: 20485253 Review.
-
Similarities and differences between pediatric and adult nonalcoholic fatty liver disease.Metabolism. 2016 Aug;65(8):1161-71. doi: 10.1016/j.metabol.2016.01.008. Epub 2016 Jan 20. Metabolism. 2016. PMID: 26961580 Review.
Cited by
-
Overweight Impacts Histological Disease Activity of De Novo Metabolic Dysfunction-Associated Steatotic Liver Disease After Liver Transplantation.Clin Transplant. 2024 Nov;38(11):e70039. doi: 10.1111/ctr.70039. Clin Transplant. 2024. PMID: 39575514 Free PMC article.
-
A free-living, walking-based, exercise programme, with exercise timed relative to breakfast, to improve metabolic health in people living with overweight and obesity: A feasibility study.PLoS One. 2024 Nov 21;19(11):e0307582. doi: 10.1371/journal.pone.0307582. eCollection 2024. PLoS One. 2024. PMID: 39570874 Free PMC article.
-
Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024).J Clin Transl Hepatol. 2024 Nov 28;12(11):955-974. doi: 10.14218/JCTH.2024.00311. Epub 2024 Nov 4. J Clin Transl Hepatol. 2024. PMID: 39544247 Free PMC article.
-
Regression of hepatic fibrosis after pharmacological therapy for nonalcoholic steatohepatitis.World J Gastrointest Pharmacol Ther. 2024 Nov 5;15(6):97381. doi: 10.4292/wjgpt.v15.i6.97381. World J Gastrointest Pharmacol Ther. 2024. PMID: 39534523 Free PMC article. Review.
-
Metabolic Dysfunction-associated Steatotic Liver Disease and Type 2 Diabetes: A Deadly Synergy.touchREV Endocrinol. 2024 Oct;20(2):5-9. doi: 10.17925/EE.2024.20.2.2. Epub 2024 Apr 23. touchREV Endocrinol. 2024. PMID: 39526052 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
